Raman Pharma is a UK based MHRA and VMD Licensed Wholesaler supplying to the Human and Veterinary Market. We are a family run company ambitiously changing the face of the Pharmaceutical and Veterinary Market alike in order to serve the needs of our customers and their patients.
Our Philosophy and business are structured around the requirements of our customers and we are committed to giving them our upmost attention and care. We believe in delivering quality and value to our customers wherever they may be.
The Herbal Horse and Pet is a South African manufacturer of a very innovative range of supplements for horses, dogs and cats. Their philosophy of using a large number of different ingredients in small amounts mimics nature in that the healing effect of the ingredients is maximised while undesirable side-effects are minimised. These unique formulations, in conjunction with 21st century scientific research and techniques are what they call “cutting edge nature”.
They are manufactured in a GMP Compliant Factory and has a large following from riders and pet owners across the world. Please follow the link to the website – www.theherbalhorse.co.uk to see all the amazing blogs and the ability to purchase these products online. The Equine and Pet Range were introduced to the UK Market in September 2014 by Raman Pharma to give the UK a taste of the future in equine and companion animal nutritional supplements.
Each year, pharmacies are required to participate in up to six public health campaigns at the request of NHS England and NHS Improvement (NHSE&I). The topics of these campaigns are agreed by NHSE&I and PSNC. At the start of 2020/21 we agreed that the campaigns would be suspended due to the COVID-19 pandemic. We have...
Contractors are reminded that this year Boxing Day (26 December 2020) is a Saturday, a normal day for the purposes of community pharmacy opening hours. Therefore, pharmacies must open on the 26th for any core and supplementary hours. The substitute bank holiday for Boxing Day this year is Monday 28 December, when contractors do not...
Contractors are reminded that if they disagree with an assessment or an identification of a recent close contact by an NHS Test and Trace contact tracer, they should ask to speak to his or her supervisor, so that the case can be escalated and reviewed. NHS Test and Trace aims to help trace recent close contacts of...
Department of Health and Social Care (DHSC) has today granted the following initial list of price concessions: Drug Pack Size Price Concession Alendronic acid 10mg tablets 28 £5.79 Amiodarone 200mg tablets 28 £2.30 Clonidine 25microgram tablets 112 £14.20 Donepezil 10mg tablets 28 £1.90 Duloxetine 20mg gastro-resistant capsules 28 £8.71 Enalapril 10mg tablets 28 £3.91 Enalapril...
In the last few months PSNC has received several reports from pharmacy contractors who have incurred significant losses from dispensing unlicensed medicinal products (specials) because prescriptions have not been issued/written correctly by the prescriber. Where prescribing of a specials product is considered appropriate by the prescriber, a prescription must be issued with the correct product...
Following representations made by PSNC, a total of 24 new unlicensed products (see table below) have been added to NHS dictionary of medicines and devices (dm+d) as ‘(Special Order)’ or ‘(Imported (Country))’ listings. Due to ongoing supply issues affecting the availability of certain licensed products and following recommendations for prescribers to consider the prescribing of...
The manufacturer Marlborough Pharmaceuticals has advised that Cloral betaine 707mg tablets are out of stock with resupply expected November 2020. In the interim, supply of an alternative imported unlicensed medicinal product (specials) is available through Alliance Healthcare Specials using PIP code: 802-0745. A prescription for a pack of 30 x Cloral betaine 707mg tablets submitted...
Following checks carried out by PSNC, 27 products (see table below) listed on the NHS dictionary of medicines and devices (dm+d) have been updated to reflect their unlicensed status. This means that the respective product entries have been annotated with either ‘(Special Order)’ or ‘(Imported (Country))’ against their Actual Medicinal Product (AMP) names. The new annotation ensures that...
Department of Health and Social Care (DHSC) has issued a medicine supply notification on the 20th August 2020 for Esomeprazole 40mg iv powder for solution (Grunenthal, Ranbaxy, Tilomed) Ranbaxy and Tilomed esomeprazole 40mg iv powder for solution is out of stock, limited supplies of Grunenthal product remain available but all stock is expected to be...
At its September 2020 meeting, PSNC agreed proposals that general practice referrals into the Community Pharmacist Consultation Service (CPCS) should commence this autumn. This decision follows recent negotiations with NHS England and NHS Improvement (NHSE&I), who have been running a pilot of the service as part of the Pharmacy Integration Programme. Work is now underway...
The MHRA will now issue all safety-critical alerts for medicines and medical devices that require action as National Patient Safety Alerts
EAMS scientific opinion issued to Merck Serono Limited for avelumab in the treatment of adults with bladder cancer that has spread beyond the bladder (advanced urothelial carcinoma) if the cancer did not get worse after chemotherapy.
EAMS scientific opinion issued to Roche Products Limited for Risdiplam 0.75 mg/ml powder for oral solution in the treatment of type 1 and type 2 Spinal Muscular Atrophy (SMA) in patients 2 months and older who are not suitable for authorised treatments.
Reporting suspected side effects or incidents to the Yellow Card scheme supports the safe use of medical products for everyone
You must get permission to export certain drugs and medicines.
Medicines from the listed parallel distributors are being recalled due to concerns that the supply chain may have been compromised and the origins of the products are unknown
List of manufacturers and their medical devices which have been granted an exemption by the MHRA. The list also includes manufacturers whose exemption expired or was cancelled. This information will be listed for 2 months after expiry or cancellation.
Summary list of field safety notices (FSNs) from medical device manufacturers from 7 to 11 September 2020.
Parallel import licenses granted in August 2020
Marketing authorisations granted in August 2020
Public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended.
Information for clinicians and patients.
Ratiopharm UK Limited and Generics [UK] Limited t/a Mylan have confirmed that the Patient Information Leaflet (PIL) within all packs and the Summary of Product Characteristics (SmPC) for Ratiopharm is missing important safety information related to potential suicide risks
Sets out medicines that cannot be exported from the UK or hoarded because they are needed for UK patients.
Summary list of field safety notices (FSNs) from medical device manufacturers from 1 to 4 September 2020.
Accord Healthcare Limited is recalling a specific batch of Amlodipine 10mg Tablets as a precautionary measure due to out of specification results obtained during stability testing.
Guidance on how to get an e-cigarette on the market in the UK, including the notification scheme and reporting problems with e-cigarettes.
Pharmacovigilance system requirements from 1 January 2021
Department of Health and Social Care and MHRA register of licensed wholesale distribution sites (human and veterinary).
List of sites granted a manufacturer or wholesale dealer licence
Guidance for the pharmaceutical industry on location and other authorised personnel requirements post transition period.
You must get permission to export certain drugs and medicines.
Product defect recall alert for Prednidale 5 mg Tablets (Vm 10434/4009) by Dechra Ltd
This is the hub for all the Veterinary Medicines Directorate's communications on the changes following the end of the Transition Period.
Service for Marketing Authorisation Holders and their associated businesses, to license veterinary medicines in the UK and report any problems with their use.
Guidance for the veterinary pharmaceutical industry on the implementation of the Northern Ireland Protocol. This guidance will be updated with more information as it becomes available.
Guidance for the pharmaceutical industry on how to apply for and manage an authorisation to place a veterinary medicine on the UK market post transition period. This guidance will be updated with more information as it becomes available.
Guidance for the pharmaceutical industry on importing and exporting veterinary medicines post transition period.
Web services, such as the Special Imports System and Adverse Event Reporting will be unavailable due to essential maintenance.
Marketing Authorisation Holders (MAHs) have informed the VMD of supply problems with the following lactating cow intramammary antibiotics.
Reporting against VMD published standards up to 31 March 2020.
For a marketing authorisation holder only; how to report a defect with a veterinary medicine.
As a vet or pharmacist, you must follow legal requirements when working with controlled drugs in veterinary medicine.
News and guidance on veterinary medicines issues affected by coronavirus (COVID-19).
Product defect recall alert for Johnson’s 4Fleas 80mg Spot-on Solution for Cats (Vm 00010/4181), by Johnson’s Veterinary Products Ltd.
VMD will re-start on-site inspections of manufacturers, wholesalers, vet practices, feed business operators and SQP retailer premises.
Details of 24 FOI requests received by the VMD in the first six months of 2020
How to legally run a business that deals with the wholesale of animal medicines (veterinary medicinal products) and the WDA Register.
Web services, such as the Special Imports System and Adverse Event Reporting will be unavailable due to essential electrical maintenance.
Report of the ten products for which most Special Import Certificates (SIC) have been issued by VMD in the UK.
The drug has been approved for routine NHS commissioning for squamous or non-squamous NSCLC
Tumour agnostic therapy demonstrates sustained efficacy
Concerns over NHS Test and Trace system exacerbated by continuing rise in cases
The drug is the first and only therapy for the ultra rare condition Familial Chylomicronaemia Syndrome (FCS)
The deadline for entering the 2020 PharmaTimes Communications Awards, Sales Awards and Marketer of the Year competitions has been extended to Friday October 2 after a last-minute spike in enquiries
Industry body says in vitro diagnostics are vital to clearing the backlog of undiagnosed conditions
Over half of patients treated with combination therapy were alive and relapse-free after five years
AZ will take the programme forward into clinical development
Middle dose tested hit the primary endpoint of the Phase II trial
People with sleep condition could be at an increased risk of adverse outcomes from COVID-19
Researchers found combination treatment showed promise against a range of cancer types
Lumevoq is designed to treat vision loss associated with Leber Hereditary Optic Neuropathy
World Evidence-based Healthcare Day takes place on 20 October
Report also highlights the impact of COVID-19 on the physical and mental health of doctors
Pharmacists, GPs and patients join arms to call for law change
Unit 2 Fleet Business Park, Sandy Lane, Church Crookham, Fleet, Hampshire, GU52 8BF
Pharmaceutical and Veterinary Licensed Distributor. WDA (H) 43703 & WDA (V) 43703.
- +44 (0)1252 260 460.
- +44 (0)1276 469 290
Monday to Friday - 09:30 – 18:30
Saturday & Sunday - Closed, Online Ordering Available